But as it stands, GLP-1 medications for weight loss currently go for $12,000 to $18,000 per patient per year
In pivotal trials, weekly semaglutide produced roughly 1415% body-weight reduction at 68 weeks (STEP 1, NEJM 2021), and tirzepatide a dual GIP/GLP-1 co-agonist reached 1822% at one year (SURMOUNT-1, NEJM 2022)
Enhancing Brain Health and Functionality Low B12 levels are strongly linked to cognitive declines, including poor concentration and memory issues
Exosomes: biogenesis, biologic function and clinical potential
Anti-Inflammatory Benefits Chronic low-grade inflammation often accompanies obesity, and while weight loss generally improves inflammatory markers, the process itself can temporarily increase certain inflammatory responses
Third-party testing provides an unbiased, objective verification of a peptides purity, identity, and concentration